PRISX
Price
$47.27
Change
+$0.09 (+0.19%)
Updated
Oct 21 closing price
Net Assets
2.04B
SFSLX
Price
$25.52
Change
+$0.04 (+0.16%)
Updated
Oct 21 closing price
Net Assets
112.43M
Interact to see
Advertisement

PRISX vs SFSLX

Header iconPRISX vs SFSLX Comparison
Open Charts PRISX vs SFSLXBanner chart's image
T. Rowe Price Financial Services
Price$47.27
Change+$0.09 (+0.19%)
VolumeN/A
Net Assets2.04B
1919 Financial Services C
Price$25.52
Change+$0.04 (+0.16%)
VolumeN/A
Net Assets112.43M
PRISX vs SFSLX Comparison Chart in %
View a ticker or compare two or three
VS
PRISX vs. SFSLX commentary
Oct 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRISX is a Buy and SFSLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRISX has more cash in the bank: 2.04B vs. SFSLX (112M). PRISX pays higher dividends than SFSLX: PRISX (1.02) vs SFSLX (0.00). PRISX was incepted earlier than SFSLX: PRISX (29 years) vs SFSLX (27 years). SFSLX (2.19) is less costly to investors than PRISX (0.94). PRISX is a more actively managed with annual turnover of: 46.90 vs. SFSLX (4.00). SFSLX has a lower initial minimum investment than PRISX: SFSLX (1000) vs PRISX (2500). PRISX annual gain was more profitable for investors over the last year : 6.28 vs. SFSLX (-8.11). PRISX return over 5 years is better than : 108.16 vs. SFSLX (20.86).
PRISXSFSLXPRISX / SFSLX
Total Expense Ratio0.932.1942%
Annual Report Gross Expense Ratio0.942.1943%
Fund Existence29 years27 years-
Gain YTD10.673-0.391-2,730%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B112M1,819%
Annual Yield % from dividends1.020.00-
Returns for 1 year6.28-8.11-77%
Returns for 3 years64.111.474,375%
Returns for 5 years108.1620.86518%
Returns for 10 years130.3431.72411%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEPSX34.97N/A
N/A
Principal Glb Emerging Markets R5
PHLAX37.26N/A
N/A
PGIM Jennison Health Sciences A
DTCCX16.08N/A
N/A
BNY Mellon Sust US Equity C
VCAAX12.84N/A
N/A
VALIC Company I Asset Allocation
BGEWX11.92-0.11
-0.91%
Baillie Gifford Emer Mkt Ex Chn Instl